Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 7Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Muscle Invasive Bladder Cancer × Clear all
NCT05860543 2024-09-25

Clinical Performance Evaluation of the C2i Test

University of Texas Southwestern Medical Center

Withdrawn
Genitourinary

Muscle Invasive Bladder Cancer

NCT02648100 2017-06-20

DIATRIBBE

Assistance Publique - Hôpitaux de Paris

Unknown
911 enrolled
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡